Literature DB >> 2612552

A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?

L Ovesen1, S Lyduch, P Ott.   

Abstract

In a prospective, randomised trial the clinical utility of a predictive warfarin maintenance dosing technique was compared with the more commonly employed empirical dosing method. A preliminary study in 35 patients established the applied technique for predicting the maintenance dosage of warfarin from the prothrombin activity on Day 4 of initial standardised warfarin administration. Forty-three patients admitted with venous thrombotic disease were investigated. All received the same loading dose of warfarin (10 mg daily) until the prothrombin percentage activity (Normotest) was less than 25%. Significantly more patients were correctly stabilised when warfarin doses were based on prediction than when they were empirically adjusted (86% vs 50%). Also, the median number of days to achieve stable anticoagulation was lower (8 vs 11 days). It is concluded that this simple predictive technique to determine the maintenance dosage of warfarin is superior to empirical dosing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612552     DOI: 10.1007/bf00562547

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

2.  Laboratory control of oral anticoagulants.

Authors:  L Poller
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

3.  [Maintenance dosage of anticoagulants (warfarin). Calculation on the basis of initial effect].

Authors:  S Lyduch; L Ovesen
Journal:  Ugeskr Laeger       Date:  1987-07-13

Review 4.  Interindividual differences in the response to oral anticoagulants.

Authors:  A M Breckenridge
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

5.  Predictability of warfarin dose requirements: theoretical considerations.

Authors:  W T Sawyer
Journal:  J Pharm Sci       Date:  1979-04       Impact factor: 3.534

6.  Drug interaction with coumarin derivative anticoagulants. Standing Advisory Committee for Haematology of the Royal College of Pathologists.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24

7.  Flexible induction dose regimen for warfarin and prediction of maintenance dose.

Authors:  A Fennerty; J Dolben; P Thomas; G Backhouse; D P Bentley; I A Campbell; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-28

Review 8.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

9.  A simple technic for predicting daily maintenance dose of warfarin.

Authors:  D B Williams; R C Karl
Journal:  Am J Surg       Date:  1979-04       Impact factor: 2.565

10.  Predicting warfarin maintenance dosage based on initial response.

Authors:  D R Miller; M A Brown
Journal:  Am J Hosp Pharm       Date:  1979-10
View more
  4 in total

1.  Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients.

Authors:  Andrew Frazer; James Rowland; Alison Mudge; Michael Barras; Jennifer Martin; Peter Donovan
Journal:  Eur J Clin Pharmacol       Date:  2019-09-11       Impact factor: 2.953

2.  Semi-empirical anticoagulation model (SAM): INR monitoring during Warfarin therapy.

Authors:  Marco Bontempi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-15       Impact factor: 2.745

Review 3.  Warfarin therapy: in need of improvement after all these years.

Authors:  Stephen E Kimmel
Journal:  Expert Opin Pharmacother       Date:  2008-04       Impact factor: 3.889

Review 4.  Adverse effects of coumarin anticoagulants.

Authors:  G F Pineo; R D Hull
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.